Navigation Links
Controversial Vaccine Raises Fury of the Church

The controversial vaccine, Gardasil, against cervical cancer could be given to schoolgirls from the age of nine to protect them against the cervical cancer causing virus,// HPV, according to yesterday’s report.

However Scots church leaders have condemned the move saying that the vaccine is giving the "green light" to under-age sex. It is because of such concerns that other countries; most notably the US has resisted vaccinating young girls as yet.

Trials of Gardasil have been completed in Glasgow successfully and administration of the drug is planned across Scotland and the rest of the UK.

Although the Joint Committee on Vaccination and Immunization was presented with research that suggested that parents supported the introduction of the drug, Gardasil still needs the approval of the Department of Health and the Scottish Executive before vaccinations can be provided in schools. It is believed that pharmaceutical firms Merck and Co and Sanofi Pasteur have already met the executive with proposals for introduction of the drug.

A spokesman for the Catholic Church said: "Our concern would be that this vaccine is seen as giving the green light to promiscuity on the grounds that the vaccine protects young people from developing the virus that is the main cause of cervical cancer."

However the rates of cervical cancer in some part of Scotland are almost a third higher than the national average thereby Scots politicians have supported the newly proposed vaccination scheme.

Roseanna Cunningham, SNP chairwoman of the Scottish Parliament's health committee, said: "Any form of vaccination that can prevent disease should be seriously considered. I don't believe there is a morality issue because it is an intervention against a deadly disease."

In addition an executive spokesman said, "We are aware of the vaccine and the clinical trials which have taken place. No decision has yet been made about its use i n Scotland."

So far trials of Gardisal on 300 women aged between 16 and 23 in Glasgow, and other countries has suggested that it is most effective when it is administered to young women before they become sexually active
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Controversial deal on public access of the human genome map
3. Controversial Levis jean ad to be withdrawn
4. GMC Gives Controversial Fertility Doctor, A Clean Chit
5. Controversial Theory Says DNA Can Be Pushed To "Dark States"
6. Harvard Begins Controversial Human Stem Cell Cloning Project
7. The Controversial Stem Cell Transplant Surgery a Failure, Patient died
8. USDA Gives Go-Ahead to Market Controversial Genetically Engineered Rice, LL601
9. Ever-Controversial Mental Health Act To Be Decided Upon
10. Vaccine to quit smoking?
11. First Vaccine Designed for Africa Cleared for Testing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... 25, 2017 , ... Somnoware, a leading provider of digital ... module. Using this new feature, sleep physicians can now predict the likelihood of ... airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The Somnoware ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the ... CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in ...
(Date:4/24/2017)... Salt Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... in their efforts to encourage sustainability, innovate new strategies to reduce waste, and support ... all-natural herbal remedy provider. They look to nature to find solutions for health issues, ...
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, eyewear, ... the rarified air of pop and film stardom.(1) Not to be left out is ... smile. Grins now run the gamut from being encrusted with jewels and precious metals ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: